Targeting PAR1 to improve current antiplatelet strategies

enthalten in: Drugs of the future | 2012

von Diaz-Ricart, M. | Bozzo, J. | Escolar, G.

TARGETS TO WATCH - Targeting PAR1 to improve current antiplatelet strategies

enthalten in: Drugs of the future | 2012

von Diaz-Ricart, M. | Bozzo, J. | Escolar, G.

MONOGRAPHS Edoxaban tosilate. Direct factor Xa inhibitor, Prevention of post-operative venous thromboembolism, Treatment of atrial fibrillation.

enthalten in: Drugs of the future | 2010

von Escolar, G. | Díaz-Ricart, M.

Edoxaban tosilate

enthalten in: Drugs of the future | 2009

von Escolar, G. | Diaz-Ricart, M.

Edoxaban tosilate

enthalten in: Drugs of the future | 2009

von Escolar, G. | Diaz-Ricart, M.

Cangrelor tetrasodium

enthalten in: Drugs of the future | 2008

von Diaz-Ricart, M. | Escolar, G. | Serradell, N. | +2

Monographs - Cangrelor Tetrasodium. P2Y12 antagonist, Antiplatelet agent.

enthalten in: Drugs of the future | 2008

von Diaz-Ricart, M. | Escolar, G. | Serradell, N. | +2

Desmoteplase

enthalten in: Drugs of the future | 2006

von Diaz-Ricart, M.

Monographs - Desmoteplase. Thrombolytic, Plasminogen activator.

enthalten in: Drugs of the future | 2006

von Diaz-Ricart, M.

Lanoteplase

enthalten in: Drugs of the future | 2002

von Diaz-Ricart, M. | Bayes, M. | Bozzo, J.